Delivery Order SPE2DR25D1052-SPE2DR26F6CT5
- Not listed
- The Defense Logistics Agency awarded a $1,169.78 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Barhemsys 5 mg/2 ml vial (2 ml units). This firm fixed-price, non-set-aside contract is scheduled for completion by December 4, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Barhemsys 10 mg/4 ml vials totaling $21,256.63 under a firm fixed price contract. The award was made on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the drug BARHEMSYS 5 MG/2 ML VIAL 2ML. The contract has a firm fixed price of $1,621.32 and a completion date of July 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,159.02, is for the supply of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type and an ultimate completion date of January 9, 2024. The contract does not have a set-aside designation, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,264.66, is for the supply of BARHEMSYS 10 MG/4 ML VIAL 4ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price and an ultimate completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4567212297 - BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $1,310.68 and has a completion date of February 11, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,215.41, is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BARHEMSYS 10 MG/4 ML VIAL 4ML. The $13,119.52 firm fixed-price delivery order has an ultimate completion date of October 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- This federal contract award for $4,193.79 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under the DLA Troop Support Medical Indefinite Delivery Contract, which has a ceiling value of up to $999,999,999 and covers a broad range of medical commodities to support military treatment programs and facilities worldwide. The specific contract deliverable is 4565675853 - BARHEMSYS 10 MG/4 ML VIAL 4ML, a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $18,914.06 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, designated as a non-set-aside contract, represents a child award under AmerisourceBergen's broader federal pharmaceutical supply agreements. The work will be performed at the company's corporate office location in Conshohocken,...
- SPE2DR25D1052Indefinite Delivery Contract
- SPE2DR25D1052-SPE2DR26F6CT5Delivery Order
The Defense Logistics Agency awarded a $1,078.30 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 13, 2026, for the supply of Barhemsys 5 mg/2 ml vials with a completion date of January 14, 2026. This firm fixed-price contract represents a non-set-aside award issued under open competition. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. Barhemsys is a prescription medication used for post-operative nausea and vomiting treatment, reflecting the ongoing pharmaceutical supply needs of military healthcare systems. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s (UEI: NWEGNLYTBDW4) substantial Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This comprehensive pharmaceutical supply vehicle enables AmerisourceBergen to deliver a broad range of medications, medical supplies, vaccines, and specialty healthcare commodities to support military treatment facilities and federal healthcare programs globally. As a major pharmaceutical distributor and critical vendor in the federal medical procurement landscape, AmerisourceBergen routinely supplies both brand-name and generic medications across multiple therapeutic domains to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/12/26 |